Clinical trials for Cancer in United States

Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

Study ID: NCT04370301

Sponsor

Fred Hutchinson Cancer Center

A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

Study ID: NCT06235801

Sponsor

M.D. Anderson Cancer Center

Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases

Study ID: NCT06173401

Sponsor

Stanford University

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Study ID: NCT05887167

Sponsor

Joshua Sasine, MD, PhD

Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic

Study ID: NCT04474301

Sponsor

M.D. Anderson Cancer Center

Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events

Study ID: NCT05123001

Sponsor

Stanford University

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Study ID: NCT02958462

Sponsor

Mayo Clinic

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Study ID: NCT05050162

Sponsor

NRG Oncology

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Study ID: NCT04715191

Sponsor

Baylor College of Medicine

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Study ID: NCT05691491

Sponsor

National Cancer Institute (NCI)